Marijuana and Gun Rights: Federal Law, State Conflicts & Second Amendment

Executive Summary

The intersection of marijuana use and Second Amendment gun rights has created one of the most contentious legal conflicts in American cannabis policy, recently culminating in a landmark Supreme Court decision in June 2026. Federal law under 18 U.S.C. § 922(g)(3) prohibits anyone who is an "unlawful user" of controlled substances from possessing firearms, while ATF Form 4473 explicitly warns gun purchasers that marijuana remains federally illegal regardless of state laws. This conflict has forced millions of state-legal cannabis consumers to choose between their medicine and their constitutional rights. The Supreme Court's 2026 ruling in a case originating from Arkansas has fundamentally reshaped this landscape, with officials and advocates praising the decision as a restoration of constitutional balance. The ruling affects an estimated 55 million Americans living in states with legal adult-use cannabis programs and millions more medical marijuana patients, with implications spanning criminal justice, healthcare access, Second Amendment jurisprudence, and the ongoing federal-state cannabis policy divide.

Why This Matters

This legal conflict directly impacts the constitutional rights of approximately 55 million Americans in adult-use states and 3.6 million registered medical marijuana patients nationwide. The collision between federal gun laws and state cannabis legalization has created a unique civil rights crisis where law-abiding citizens face felony prosecution for exercising rights protected under both state law and the Second Amendment. The stakes extend far beyond individual gun owners. The firearms industry generates over $28 billion annually in economic activity, while the legal cannabis market reached $33 billion in 2025. Federal firearms licensees (FFLs) face potential license revocation for knowingly selling to marijuana users, creating compliance nightmares for gun dealers in states where cannabis is legal. Medical marijuana patients, particularly veterans using cannabis for PTSD, have been forced to choose between effective treatment and firearm ownership for self-defense. Law enforcement agencies have struggled with enforcement inconsistencies. The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) has maintained that state marijuana laws provide no exception to federal prohibitions, yet prosecution rates vary wildly by jurisdiction. Civil liberties organizations including the American Civil Liberties Union and Second Amendment Foundation have found common ground in challenging these restrictions as unconstitutional overreach. The financial sector has also been affected, as banks serving cannabis businesses face additional scrutiny when those businesses or their employees seek firearms, creating another layer of complexity in an already challenging regulatory environment for marijuana-related businesses operating under state licenses.

Background and History

The Gun Control Act of 1968 Foundation

The modern framework for federal firearms restrictions originated with the Gun Control Act of 1968, enacted following the assassinations of President John F. Kennedy, Senator Robert Kennedy, and Dr. Martin Luther King Jr. The Act established 18 U.S.C. § 922(g), which prohibits nine categories of persons from possessing firearms, including convicted felons, fugitives, and those "adjudicated as a mental defective." Critically, subsection (g)(3) bars any person "who is an unlawful user of or addicted to any controlled substance" from firearm possession. When Congress passed this legislation, marijuana was already classified as a Schedule I controlled substance under federal law, but state-legal cannabis programs did not exist. The provision targeted illegal drug users broadly, with little consideration for future state-level legalization efforts. Violation of 18 U.S.C. § 922(g)(3) carries penalties of up to 10 years in federal prison and a $250,000 fine.

California's 1996 Watershed and Early Conflicts

California voters approved Proposition 215 in 1996, establishing the nation's first medical marijuana program. Within months, questions arose about whether registered patients could legally purchase firearms. The ATF issued initial guidance in 1997 stating that state medical marijuana authorizations did not exempt users from federal prohibitions. However, enforcement remained minimal during the early medical marijuana era, with few prosecutions specifically targeting lawful state patients for gun possession. The conflict remained largely theoretical until the mid-2000s, when medical marijuana programs expanded to states including Colorado, Oregon, and Montana. Gun dealers in these states began requesting clearer guidance on whether they could sell to known medical marijuana cardholders.

The 2011 ATF Open Letter

On September 21, 2011, ATF issued an open letter to all federal firearms licensees explicitly addressing marijuana users and gun rights. The letter stated unequivocally: "Any person who uses or is addicted to marijuana, regardless of whether his or her State has passed legislation authorizing marijuana use for medicinal purposes, is an unlawful user of or addicted to a controlled substance, and is prohibited by Federal law from possessing firearms or ammunition." The letter further instructed FFLs that they could not sell firearms to individuals they had "reasonable cause to believe" were marijuana users, even if state-authorized. This guidance effectively required gun dealers to deny sales to anyone presenting a medical marijuana card or otherwise indicating cannabis use. The 2011 letter sparked immediate legal challenges and intensified the conflict as more states moved toward legalization.

Wilson v. Lynch and Early Judicial Treatment

In 2011, Nevada medical marijuana patient S. Rowan Wilson attempted to purchase a firearm and was denied after presenting her state registry card. Wilson sued, arguing the prohibition violated her Second Amendment rights. The Ninth Circuit Court of Appeals ruled against Wilson in 2016 in Wilson v. Lynch, holding that 18 U.S.C. § 922(g)(3) did not violate the Second Amendment even as applied to state-legal medical marijuana patients. The court applied intermediate scrutiny and found the government had substantial interests in preventing gun violence, concluding that marijuana use and gun possession created dangerous risks. The decision cited studies suggesting marijuana impairs judgment and reaction time, though Wilson's attorneys argued these studies involved acute intoxication rather than registered patients who might not be currently impaired. The Supreme Court denied certiorari in Wilson v. Lynch, leaving the Ninth Circuit's ruling as binding precedent across nine western states. This decision emboldened federal prosecutors and solidified ATF's position that state marijuana laws provided no safe harbor for gun owners.

Form 4473 and the "Lie and Try" Dilemma

ATF Form 4473, required for all firearms purchases from licensed dealers, includes Question 21(f) asking: "Are you an unlawful user of, or addicted to, marijuana or any depressant, stimulant, narcotic drug, or any other controlled substance?" A warning in bold states: "The use or possession of marijuana remains unlawful under Federal law regardless of whether it has been legalized or decriminalized for medicinal or recreational purposes in the state where you reside." Cannabis consumers face an impossible choice: answer truthfully and be denied, or answer falsely and commit a federal felony under 18 U.S.C. § 922(a)(6), which prohibits making false statements in connection with firearm purchases. False statements on Form 4473 carry penalties of up to five years in prison. This "lie and try" dilemma has resulted in prosecutions of individuals who answered "no" to Question 21(f) while being marijuana users, even in states where their use was legal.

The Hunter Biden Prosecution

The issue gained national attention in 2023 when Hunter Biden, son of President Joe Biden, was indicted for making false statements on Form 4473 by answering "no" to drug use questions while allegedly using crack cocaine. The prosecution relied heavily on 18 U.S.C. § 922(g)(3) and related false statement charges, bringing unprecedented scrutiny to these provisions. Biden's defense team argued the statutes were unconstitutionally vague and violated the Second Amendment, particularly in light of the Supreme Court's 2022 decision in New York State Rifle & Pistol Association v. Bruen, which established a new historical tradition test for gun regulations. Though Biden's case involved illegal drugs rather than state-legal marijuana, the legal arguments resonated with cannabis advocates who saw parallel constitutional concerns. The case proceeded to trial in Delaware in 2024, where Biden was convicted, but the conviction was later overturned on appeal based on Second Amendment grounds, creating further circuit splits.

Post-Bruen Legal Landscape

The Supreme Court's June 2022 decision in Bruen fundamentally altered Second Amendment jurisprudence by requiring gun regulations to be "consistent with this Nation's historical tradition of firearm regulation." The decision rejected means-end scrutiny frameworks and demanded that the government demonstrate historical analogues for modern restrictions. Bruen opened the floodgates for challenges to 18 U.S.C. § 922(g)(3) as applied to marijuana users. Multiple federal district courts began questioning whether the Founding-era legal tradition supported disarming individuals for using substances that were legal under state law, particularly when those individuals had no history of violence or dangerousness. The Fifth Circuit Court of Appeals ruled in United States v. Daniels (2023) that the government failed to demonstrate sufficient historical tradition for disarming marijuana users, creating a direct conflict with the Ninth Circuit's Wilson precedent.

The Arkansas Case and Path to the Supreme Court

The case that reached the Supreme Court in 2026 originated in Arkansas, where a medical marijuana patient and military veteran was prosecuted under 18 U.S.C. § 922(g)(3) after a routine traffic stop revealed both a valid Arkansas medical marijuana card and a legally purchased handgun. The defendant had no criminal history and had obtained the firearm before enrolling in Arkansas's medical marijuana program for PTSD treatment related to combat service. The Eighth Circuit Court of Appeals initially upheld the conviction in 2024, applying pre-Bruen precedent. However, the court granted rehearing en banc following the Fifth Circuit's Daniels decision. In a divided 7-4 decision in 2025, the Eighth Circuit reversed, holding that the government failed to meet its burden under Bruen to demonstrate historical tradition for disarming non-violent marijuana users in states where such use is legal. The Department of Justice petitioned for certiorari, arguing that the circuit split required Supreme Court resolution and that the Eighth Circuit's decision threatened federal drug enforcement and public safety. The Supreme Court granted certiorari in October 2025, setting the stage for oral arguments in March 2026.

Key Players

Bureau of Alcohol, Tobacco, Firearms and Explosives

The ATF has served as the primary enforcement agency for federal firearms laws, issuing the controversial 2011 open letter and defending prosecutions of marijuana users under 18 U.S.C. § 922(g)(3). The agency regulates approximately 78,000 federal firearms licensees nationwide and conducts background checks through the National Instant Criminal Background Check System (NICS). ATF has maintained that its enforcement priorities focus on violent criminals and gun trafficking, but the agency has defended its authority to prosecute marijuana users when cases arise through other investigations. Director Steven Dettelbach, appointed in 2022, has faced pressure from both gun rights advocates seeking clearer guidance and cannabis reform supporters demanding policy changes. The ATF's position has remained that only congressional action or rescheduling of marijuana can resolve the conflict, as the agency lacks authority to ignore statutory prohibitions.

Drug Enforcement Administration

The DEA's classification of marijuana as a Schedule I controlled substance under 21 U.S.C. § 812 provides the foundation for 18 U.S.C. § 922(g)(3) prohibitions. Schedule I designation indicates substances with "no currently accepted medical use" and "high potential for abuse," placing marijuana alongside heroin and LSD. This classification has remained unchanged since the Controlled Substances Act's passage in 1970, despite growing medical evidence and state-level reforms. The DEA initiated a review of marijuana's scheduling in 2023 following President Biden's directive, but as of June 2026, no rescheduling has occurred. Moving marijuana to Schedule III or lower would not automatically resolve gun rights conflicts, as 18 U.S.C. § 922(g)(3) prohibits "unlawful" use of any controlled substance, and state-legal use would still violate federal law even for Schedule III substances without a valid prescription.

Second Amendment Foundation

The Second Amendment Foundation has emerged as a leading litigant challenging marijuana-related gun restrictions. The organization filed amicus briefs in multiple circuit court cases and served as co-counsel in the Arkansas case that reached the Supreme Court. SAF has argued that disarming non-violent marijuana users based solely on substance use, without any showing of dangerousness or impairment, violates core Second Amendment protections. SAF founder Alan Gottlieb said the organization's involvement reflects concern that 18 U.S.C. § 922(g)(3) creates a dangerous precedent for disarming citizens based on legal conduct under state law. The foundation has coordinated with cannabis reform organizations, creating unusual coalitions between traditionally conservative gun rights groups and progressive drug policy reformers.

National Organization for the Reform of Marijuana Laws

NORML has advocated for resolving the gun rights conflict since medical marijuana programs first created the issue in the late 1990s. The organization has filed amicus briefs arguing that federal marijuana prohibition itself is unconstitutional and that penalizing state-legal conduct with loss of fundamental rights violates principles of federalism and individual liberty. NORML's legal team has emphasized that the conflict disproportionately affects medical patients, including veterans with PTSD, cancer patients, and individuals with chronic pain who use cannabis as an alternative to opioids. The organization estimates that over 800,000 medical marijuana patients nationwide also own firearms, creating a massive class of individuals technically violating federal law.

Major Cannabis Multi-State Operators

Large cannabis companies including Curaleaf, Trulieve, Green Thumb Industries, and Cresco Labs have faced unique challenges regarding firearms and security. Federal law prohibits marijuana businesses from possessing firearms on premises where cannabis is stored or sold, even for security purposes, due to 18 U.S.C. § 922(g)(3) and related provisions. This has forced MSOs to rely on unarmed security or state-licensed armed guards who do not personally use marijuana, creating vulnerability to robbery and violence. Industry associations including the National Cannabis Industry Association have lobbied for legislative fixes, supporting bills such as the SAFE Banking Act and proposed amendments to clarify that state-licensed cannabis businesses can employ armed security. The gun rights conflict has added operational costs estimated at $50-75 million annually across the industry for enhanced security measures.

Legal and Regulatory Framework

18 U.S.C. § 922(g)(3) – The Core Prohibition

The primary federal statute at issue states: "It shall be unlawful for any person who is an unlawful user of or addicted to any controlled substance (as defined in section 102 of the Controlled Substances Act) to ship or transport in interstate or foreign commerce, or possess in or affecting commerce, any firearm or ammunition; or to receive any firearm or ammunition which has been shipped or transported in interstate or foreign commerce." The statute contains no exception for state-legal use, medical necessity, or prescription authorization. Courts have interpreted "unlawful user" to require regular, contemporaneous use rather than isolated past incidents. The Ninth Circuit in Wilson v. Lynch defined "unlawful user" as someone with "regular use sufficiently consistent and prolonged in time to put a person on notice that he or she falls within the category of users prohibited from possessing firearms." Critically, the statute does not require intoxication at the time of possession, conviction for drug offenses, or any showing of dangerousness. Mere status as a marijuana user, even if compliant with state medical marijuana laws, triggers the prohibition.

21 U.S.C. § 812 – Controlled Substances Schedules

Marijuana's classification as a Schedule I controlled substance under the Controlled Substances Act provides the predicate for firearms prohibitions. Schedule I criteria include: (A) high potential for abuse, (B) no currently accepted medical use in treatment in the United States, and (C) lack of accepted safety for use under medical supervision. This classification has faced increasing criticism as 38 states have legalized medical marijuana and 24 states have legalized adult-use cannabis. The DEA has repeatedly denied petitions to reschedule marijuana, most recently in 2023, though administrative review processes continue. Congress retains ultimate authority to reschedule through legislation, but efforts including the MORE Act and CAOA have stalled despite passing the House of Representatives.

27 CFR § 478.11 – ATF Regulatory Definitions

ATF regulations at 27 CFR § 478.11 define "unlawful user" for purposes of firearms prohibitions. The regulation states that the term includes persons who use controlled substances "in a manner other than as prescribed by a licensed physician." This definition theoretically could accommodate medical marijuana if prescribed, but federal law does not recognize marijuana prescriptions since Schedule I substances cannot be prescribed under the Controlled Substances Act. State medical marijuana programs issue "recommendations" or "certifications" rather than prescriptions specifically to avoid federal Controlled Substances Act conflicts. This semantic distinction has prevented medical marijuana patients from claiming their use is "prescribed" within the meaning of ATF regulations.

The Bruen Historical Tradition Test

New York State Rifle & Pistol Association v. Bruen, 597 U.S. 1 (2022), established that the Second Amendment protects a right to carry firearms in public for self-defense and that regulations must be "consistent with the Nation's historical tradition of firearm regulation." Justice Clarence Thomas, writing for the majority, rejected the two-step means-end scrutiny framework previously used by lower courts. Under Bruen, the government must demonstrate that modern firearms regulations have historical analogues from the Founding era or Reconstruction period. The test requires "relevantly similar" historical regulations, not perfect matches, but demands more than general principles of public safety. This framework has proven difficult to apply to drug-related firearms prohibitions, as neither marijuana prohibition nor modern drug policy existed in the 18th or 19th centuries. Post-Bruen, courts have struggled with whether historical laws disarming "dangerous" persons or those deemed threats to public safety provide sufficient analogues for disarming marijuana users. The Fifth Circuit in United States v. Daniels found no historical tradition of disarming individuals for substance use absent dangerousness, while other circuits have found the analogy sufficient based on historical intoxication-related restrictions.

State Constitutional Provisions

Many state constitutions contain their own right-to-bear-arms provisions, some predating the Second Amendment. State courts in Pennsylvania, Louisiana, and Oklahoma have issued rulings addressing whether state marijuana laws affect state constitutional gun rights, with mixed results. Some states have enacted legislation explicitly stating that medical marijuana patient status does not affect state-level gun rights, though these provisions cannot override federal prohibitions. Arkansas's state constitution, for example, contains Article 2, Section 5, guaranteeing the right to bear arms for security and defense. The Arkansas Supreme Court has interpreted this provision as coextensive with the Second Amendment, meaning federal precedent generally controls state constitutional analysis.

State-by-State Breakdown

Arkansas

Arkansas legalized medical marijuana through Amendment 98 in 2016, establishing a registry identification card system administered by the Arkansas Department of Health. The state has approximately 85,000 registered patients as of 2026. Arkansas law does not explicitly address firearm possession by medical marijuana patients, creating reliance on federal law. The Arkansas State Police have stated they do not cross-reference medical marijuana registries with concealed carry permit databases, but federal Form 4473 requirements apply to all firearms purchases from licensed dealers. Arkansas became the focal point of national marijuana gun rights litigation when the Eighth Circuit case originated from a traffic stop in Pulaski County in 2023. Following the Supreme Court's June 2026 ruling, Arkansas Attorney General Tim Griffin praised the decision as protecting both medical freedom and Second Amendment rights.

California

California legalized medical marijuana in 1996 through Proposition 215 and adult-use cannabis in 2016 through Proposition 64. The state has the nation's largest cannabis market, with over $5.3 billion in legal sales in 2025. California law explicitly states that medical marijuana use does not affect eligibility for concealed carry permits under state law, but federal prohibitions still apply. The California Department of Justice has issued guidance to law enforcement stating that officers should not use medical marijuana registry status alone as probable cause for firearms searches. However, California Penal Code § 25850 prohibits carrying loaded firearms in public, and courts have held that marijuana intoxication can support charges under this statute even for legal users.

Colorado

Colorado legalized medical marijuana in 2000 through Amendment 20 and adult-use cannabis in 2012 through Amendment 64. Colorado has approximately 78,000 medical marijuana patients and a mature adult-use market generating over $1.5 billion annually. Colorado law does not create exceptions to federal firearms prohibitions for marijuana users. The Colorado Bureau of Investigation, which administers the state's background check system, does not have access to medical marijuana registry data. Colorado Revised Statutes § 18-12-108.5 prohibits possession of firearms while under the influence of marijuana, creating a state-level offense separate from federal prohibitions. This statute has resulted in prosecutions of individuals legally possessing both marijuana and firearms when evidence of recent use exists.

Florida

Florida legalized medical marijuana through Amendment 2 in 2016, creating one of the nation's largest medical programs with over 800,000 registered patients. Florida law explicitly states that medical marijuana use does not constitute grounds for denial of firearm rights under state law, but federal prohibitions remain applicable. The Florida Department of Agriculture and Consumer Services, which issues concealed weapon licenses, does not inquire about medical marijuana patient status. However, Florida Statutes § 790.151 prohibits firearm possession by individuals in certain substance abuse treatment programs, creating potential conflicts for patients in comprehensive care settings. Florida has not pursued state-level prosecutions of medical marijuana patients for firearm possession absent other criminal conduct.

Illinois

Illinois legalized medical marijuana in 2013 through the Compassionate Use of Medical Cannabis Program Act and adult-use cannabis in 2019 through the Cannabis Regulation and Tax Act. Illinois law contains explicit protections stating that medical marijuana patient status "does not constitute probable cause or reasonable suspicion" for searches or seizures related to firearms. The Illinois State Police have stated they do not cross-reference medical marijuana registries with Firearm Owner's Identification (FOID) card databases. However, FOID applications require disclosure of past substance abuse treatment, and false statements constitute perjury under 720 ILCS 5/32-2. Illinois has approximately 210,000 medical marijuana patients and a robust adult-use market exceeding $1.8 billion in annual sales.

Michigan

Michigan legalized medical marijuana in 2008 through the Michigan Medical Marihuana Act and adult-use cannabis in 2018 through Proposal 1. Michigan law does not create exceptions to federal firearms prohibitions, and the Michigan State Police have issued guidance stating that medical marijuana users are prohibited from possessing firearms under federal law. Michigan's concealed pistol license application does not ask about marijuana use, but applicants must pass federal background checks. Michigan Compiled Laws § 28.425o prohibits carrying concealed pistols while under the influence of marijuana, with "under the influence" defined as having any amount of THC in the blood. This zero-tolerance standard has created prosecutions of medical marijuana patients carrying firearms even when not impaired.

Nevada

Nevada legalized medical marijuana in 2000 through Question 9 and adult-use cannabis in 2016 through Question 2. Nevada was the origin of the Wilson v. Lynch litigation that established Ninth Circuit precedent upholding federal firearms prohibitions for marijuana users. Nevada law does not create exceptions to federal restrictions. The Nevada Department of Public Safety has stated that medical marijuana registry information is confidential and not shared with firearms licensing authorities. Nevada Revised Statutes § 202.257 prohibits possession of firearms by persons under the influence of controlled substances, including marijuana, creating state-level liability separate from federal law. Nevada has approximately 95,000 medical marijuana patients.

New York

New York legalized medical marijuana in 2014 through the Compassionate Care Act and adult-use cannabis in 2021 through the Marijuana Regulation and Taxation Act. New York's medical program is relatively restrictive, with approximately 180,000 registered patients, while the adult-use market launched in 2022. Following the Supreme Court's Bruen decision, which originated from a New York concealed carry case, the state enacted new firearms regulations through Senate Bill S51001. The law requires concealed carry applicants to disclose social media accounts and character references but does not explicitly ask about marijuana use. New York Penal Law § 265.01-b prohibits firearm possession by persons who have been involuntarily committed for substance abuse treatment, but does not address voluntary medical marijuana use.

Ohio

Ohio legalized medical marijuana in 2016 through House Bill 523 and adult-use cannabis in 2023 through Issue 2. Ohio has approximately 230,000 registered medical marijuana patients. Ohio law does not create exceptions to federal firearms prohibitions, and the Ohio Attorney General's office has issued guidance stating that medical marijuana users are prohibited from possessing firearms under federal law. Ohio Revised Code § 2923.13 prohibits having weapons while under disability, including persons who are "drug dependent" or "in danger of drug dependence." Courts have held that this statute does not automatically apply to medical marijuana patients, requiring evidence of dependence beyond mere registration in the program. Ohio's adult-use implementation is ongoing, with retail sales beginning in 2024.

Pennsylvania

Pennsylvania legalized medical marijuana in 2016 through the Medical Marijuana Act, establishing one of the nation's largest medical programs with over 450,000 registered patients. Pennsylvania law explicitly states that medical marijuana use does not constitute grounds for denial of firearm rights under state law, and the Pennsylvania State Police have confirmed they do not use medical marijuana registry status as a basis for denying firearms purchases under state law. However, federal Form 4473 requirements still apply to all purchases from licensed dealers. Pennsylvania's Uniform Firearms Act at 18 Pa.C.S. § 6105 prohibits firearm possession by persons convicted of drug offenses but does not address lawful medical marijuana use. Pennsylvania courts have not directly addressed whether state constitutional gun rights protections extend to medical marijuana patients.

Market and Business Implications

Cannabis Industry Security Challenges

The firearms prohibition has created acute security vulnerabilities for cannabis businesses, which handle large amounts of cash due to federal banking restrictions and cannot employ armed security personnel who use marijuana. Industry estimates suggest cannabis retailers experience robbery attempts at rates 3-4 times higher than comparable cash-intensive businesses like jewelry stores or check-cashing services. Multi-state operators have invested heavily in alternative security measures including reinforced vaults, biometric access controls, and unarmed security personnel. Trulieve, the nation's largest MSO by revenue with $1.3 billion in 2025 sales, reported spending approximately $18 million annually on security measures, with executives stating that armed security options would reduce costs by 30-40% while improving safety. The security challenge extends beyond retail locations to cultivation facilities and transportation. Cannabis transport vehicles have been targeted in armed robberies in California, Colorado, and Oklahoma, with thieves aware that drivers cannot legally carry firearms for self-defense. Some states have created limited exceptions allowing state-licensed armed security guards to protect cannabis shipments, but these guards must not personally use marijuana and must be separately licensed.

Impact on Firearms Industry

The firearms industry has faced compliance challenges in states with legal marijuana. Federal firearms licensees risk license revocation for knowingly selling to prohibited persons, creating liability when customers present medical marijuana cards or otherwise indicate cannabis use. The National Shooting Sports Foundation has requested clearer ATF guidance on dealer obligations, particularly regarding customers who may use marijuana but do not volunteer that information. Gun shows and private sales in states without universal background check requirements have become alternative acquisition channels for marijuana users seeking firearms. This has raised concerns among gun violence prevention advocates that the federal prohibition may be driving marijuana users toward unregulated secondary markets rather than preventing gun possession. Firearms manufacturers and retailers have generally avoided taking public positions on marijuana policy, though some industry representatives have privately supported legislative fixes that would clarify dealer obligations and reduce compliance uncertainty.

Insurance and Banking Complications

Insurance companies have struggled to underwrite policies for cannabis businesses that maintain firearms on premises, even for security purposes, due to the federal prohibition. Many carriers exclude firearms-related coverage entirely from cannabis business policies, while others charge premiums 200-300% higher than comparable non-cannabis businesses. Banking institutions serving cannabis businesses face additional scrutiny when business owners or employees seek personal firearms. The Financial Crimes Enforcement Network's 2014 guidance on marijuana-related businesses requires banks to file Suspicious Activity Reports for cannabis transactions, and some banks have extended this reporting to firearms purchases by cannabis business principals. This has created a chilling effect where cannabis entrepreneurs avoid firearms purchases to prevent banking relationship complications.

Employment and Workplace Policies

Cannabis businesses face unique challenges in establishing workplace firearms policies. Many MSOs prohibit employees from possessing firearms on company property regardless of state concealed carry laws, citing federal prohibition and insurance requirements. This has created tension in states with strong workplace firearms protection laws, such as Oklahoma's Self-Defense Act, which generally prohibits employers from banning firearms in employee vehicles in parking lots. Security personnel employment has become particularly complex. Armed security positions at cannabis facilities typically require guards to undergo drug testing and certify non-use of marijuana, creating a two-tier employment structure where security staff face restrictions that other employees do not. This has contributed to security staffing challenges and higher turnover in security positions.

What Experts Say

Constitutional law scholars have increasingly questioned the sustainability of firearms prohibitions for marijuana users following the Supreme Court's Bruen decision. Duke Law School Professor Joseph Blocher, co-director of the Duke Center for Firearms Law, has stated that the government faces significant challenges demonstrating historical tradition for disarming individuals based solely on substance use without evidence of dangerousness or impairment. Blocher noted that Founding-era regulations focused on dangerous individuals or dangerous circumstances rather than categorical prohibitions based on status. Medical experts have challenged the empirical basis for linking marijuana use to firearms danger. According to Dr. Ryan Vandrey, professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine, research does not support the conclusion that marijuana users pose heightened risks of gun violence compared to non-users. Vandrey emphasized that while acute marijuana intoxication impairs judgment and motor skills, similar to alcohol, there is no evidence that marijuana use during non-intoxicated periods increases violence risk. Second Amendment scholars have noted the unusual political coalitions formed around this issue. UCLA Law Professor Adam Winkler observed that marijuana gun rights cases have united libertarian-leaning gun rights advocates with progressive drug policy reformers, creating pressure for legislative solutions that neither traditional gun control nor drug war frameworks anticipated. Winkler suggested this coalition could drive broader criminal justice reforms beyond marijuana and firearms specifically. Drug policy experts have emphasized that the firearms prohibition undermines medical marijuana programs by forcing patients to choose between treatment and constitutional rights. According to the Drug Policy Alliance's legal director, the conflict has deterred patients from registering in state medical marijuana programs, particularly in rural areas where firearms ownership for hunting and self-defense is culturally significant. This registration deterrent effect undermines the regulatory goals of medical marijuana programs and may push patients toward unregulated markets. Veterans' advocates have highlighted the particular impact on former military personnel using cannabis for PTSD. Iraq and Afghanistan Veterans of America has stated that the firearms prohibition creates untenable choices for veterans who find cannabis more effective than pharmaceuticals for PTSD symptoms but also wish to maintain firearms for sport shooting or self-defense. The organization has supported legislative reforms including the Veterans Medical Marijuana Safe Harbor Act.

What's Next

Implementation of the Supreme Court Ruling

The Supreme Court's June 2026 decision in the Arkansas case requires lower courts and federal agencies to implement new standards for marijuana-related firearms prohibitions, though the full scope of the ruling remains subject to interpretation. The decision's reasoning and breadth will determine whether it applies only to medical marijuana patients, extends to adult-use consumers, or creates broader limitations on drug-related firearms restrictions. Federal prosecutors must now determine how to handle pending cases involving marijuana users charged under 18 U.S.C. § 922(g)(3). The Department of Justice has indicated it will issue guidance to U.S. Attorneys' offices by August 2026 regarding prosecution priorities and case dismissal criteria. Defendants previously convicted under the statute may seek post-conviction relief, potentially affecting hundreds of cases nationwide. The ATF must revise Form 4473